SATO VICKI L - Insider Non-Derivative Transactions at Denali Therapeutics Inc. (DNLI) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 13, 2024, SATO VICKI L's relationship to Denali Therapeutics Inc. (DNLI) is Director, and currently has 115,156 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other DNLI insiders.

Data Source: SEC.
SATO VICKI L - Insider Non-Derivative Transactions of DNLI Common Stock
SATO VICKI L - Insider Non-Derivative Transactions at DNLI
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 14, 2024 Sell -- (Common Stock) 1020 30 115156
Sep 4, 2024 Sell -- (Common Stock) 100 25.37 116176
Sep 4, 2024 Sell -- (Common Stock) 2980 24.99 116276
Jul 2, 2024 Sell -- (Common Stock) 100 22.86 119256
Jul 2, 2024 Sell -- (Common Stock) 2980 22.12 119356
Jun 1, 2024 Acquisition -- (Common Stock) 5967 0 122336
May 16, 2024 Sell -- (Common Stock) 1674 20.39 116369
Apr 16, 2024 Sell -- (Common Stock) 1666 18.29 118043
Mar 16, 2024 Sell -- (Common Stock) 1666 20.1 119709
Feb 16, 2024 Sell -- (Common Stock) 1666 18.37 121375
Jan 17, 2024 Sell -- (Common Stock) 1666 18.42 123041
Dec 16, 2023 Sell -- (Common Stock) 1666 23.39 124707
Nov 16, 2023 Sell -- (Common Stock) 1666 19.13 126373
Oct 17, 2023 Sell -- (Common Stock) 1666 20.66 128039
Sep 16, 2023 Sell -- (Common Stock) 40 24.35 129705
Sep 16, 2023 Sell -- (Common Stock) 1626 23.6 129745
Aug 16, 2023 Sell -- (Common Stock) 1666 24.3 131371
Jul 18, 2023 Sell -- (Common Stock) 1666 29.6 133037
Jun 29, 2023 Sell -- (Common Stock) 1114 29.98 134703
Jun 29, 2023 Sell -- (Common Stock) 552 29.55 135817
Jun 2, 2023 Acquisition -- (Common Stock) 4216 0 136369